Research Paper Volume 15, Issue 15 pp 7831—7843
Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
Figure 1. Venn diagram of drug-disease intersection target.
Figure 1. Venn diagram of drug-disease intersection target.